STUDY_ID,INCLUDE,X1,bibtype,abstract,author,isbn,journal,keywords,pages,title,url,volume,year,number,annote,doi,edition,language,pmid,ROUND1INC,ROUND1REV,ROUND2INC,ROUND2REV,REVIEWERS,FT_REV,DOWNLOADED
19430,YES,Sivaraman2016,Article,"Kocuria species were placed previously under the genus Micrococcus, are skin and oropharynx commensals in mammals, including man. A rare bacteria, Kocuria kristinae isolated from a new born with umbilical sepsis. Identification and antibiotic susceptibility was done by Vitek 2 compact system (Biomerieux). The isolate was sensitive to higher antibiotics like vancomycin, teicoplanin and linezolid. As this new pathogen resembles coagulase negative staphylococcus, it should not be misidentified.",U Sivaraman and P Subramanian and K Ramakrishnan and K S Seetha,"0973-709X2249-782X",Journal of Clinical and Diagnostic Research,"Gram staining,Kocuria,Kocuria kristinae,antibiotic sensitivity,article,bacterial strain,bacterium culture,case report,catalase,ciprofloxacin,cotrimoxazole,daptomycin,disk diffusion,erythromycin,female,fever,furazolidone,gentamicin,glycopeptide,human,levofloxacin,linezolid,multidrug resistant bacterial strain,newborn,newborn sepsis,nonhuman,oxacillin,penicillin derivative,pus,rifampicin,sepsis,teicoplanin,tetracycline,umbilical sepsis,vancomycin",DD01--DD02,{Umbilical sepsis caused by multidrug resistant strain of Kocuria Kristinae in a new born: A case report},http://www.embase.com/search/results?subaction=viewrecord{\&}from=export{\&}id=L609700098 http://dx.doi.org/10.7860/JCDR/2016/15665.7560 http://rd8hp6du2b.search.serialssolutions.com?sid=EMBASE{\&}issn=0973709X{\&}id=doi:10.7860{\%}2FJCDR{\%}2F2016{\%}2F15665.7560{\&}atitle=Umbi,10,2016,4,NA,NA,NA,NA,NA,MAYBE,Jake,YES,Ayomide,Ayomide,Ayomide,yes
19257,MAYBE,Sidjabat2014,Article,"A patient was colonized by IMP-4-producing Enterobacter cloacae and Escherichia coli strains for 7 months. IMP-4-producing E. cloacae strains were first and last isolated at day 33 and at 8 months after admission, respectively. IMP-4-producing E. coli strains were first and last isolated at days 88 and 181 after admission, respectively. The E. cloacae and E. coli isolates shared identical genetic features in terms of blaIMP-4, blaTEM-1, qnrB2, aacA4, HI2 plasmids, and ISCR1. This study shows the first prolonged colonization with in vivo interspecies transfer of blaIMP-4. Copyright",H E Sidjabat and C Heney and N M George and G R Nimmo and D L Paterson,"1098-660X0095-1137",Journal of Clinical Microbiology,"Enterobacter cloacae,Enterococcus faecalis,Escherichia coli,IMP 4 producing Enterobacteriaceae,ISCR1 gene,Pseudomonas aeruginosa,Serratia marcescens,Stenotrophomonas maltophilia,aacA4 gene,adult,allograft,amikacin,antibiotic resistance,article,bacterial colonization,bacterial gene,bacterial infection,bacterial strain,bacterium isolate,bacterium isolation,beta lactamase TEM 1,blaIMP 4 gene,blaTEM 1 gene,carbapenemase,carbapenemase producing Enterobacteriaceae,case report,cefepime,cefotaxime,cefoxitin,ceftazidime,ciprofloxacin,cotrimoxazole,debridement,ertapenem,female,gene identification,gene transfer,genetic similarity,gentamicin,human,imipenem,infection prevention,lung burn,meropenem,meropenem resistant Enterobacter cloacae,meropenem resistant Escherichia coli,meropenem resistant Pseudomonas aeruginosa,middle aged,nonhuman,piperacillin plus tazobactam,polymerase chain reaction,qnrB2 gene,species differentiation,strain identification,tobramycin,tracheal aspiration procedure,vancomycin",3816--3818,{Interspecies transfer of blaimp-4 in a patient with prolonged colonization by IMP-4-producing enterobacteriaceae},http://www.embase.com/search/results?subaction=viewrecord{\&}from=export{\&}id=L600054381 http://dx.doi.org/10.1128/JCM.01491-14 http://rd8hp6du2b.search.serialssolutions.com?sid=EMBASE{\&}issn=1098660X{\&}id=doi:10.1128{\%}2FJCM.01491-14{\&}atitle=Interspecies+transfer+of,52,2014,10,NA,NA,NA,NA,NA,NO,Erica,MAYBE,Brooke,Allison,Ayomide,yes
16682,MAYBE,Pletz2006,Article,NA,M W R Pletz and R V Fugit and L McGee and J J Glasheen and D L Keller and T Welte and K P Klugman,"1080-60401080-6059",Emerging Infectious Diseases,"Streptococcus pneumoniae,adult,amino acid substitution,antibiotic resistance,antibiotic sensitivity,antibiotic therapy,bacterial gene,bacterial strain,bacterium culture,bacterium isolate,case report,ceftriaxone,chronic obstructive lung disease,ciprofloxacin,enzyme polymorphism,fluoroquinolone resistant streptococcus pneumoniae,gatifloxacin,gene mutation,gene sequence,human,letter,levofloxacin,low drug dose,male,mutational analysis,nonhuman,penicillin G,quinoline derived antiinfective agent,respiratory tract infection",1462--1463,{Fluoroquinolone-resistant Streptococcus pneumoniae [4]},http://www.embase.com/search/results?subaction=viewrecord{\&}from=export{\&}id=L44455234 http://rd8hp6du2b.search.serialssolutions.com?sid=EMBASE{\&}issn=10806040{\&}id=doi:{\&}atitle=Fluoroquinolone-resistant+Streptococcus+pneumoniae+{\%}5B4{\%}5D{\&}stitle=Emerg.+Infect.+Dis.{\&},12,2006,9,NA,NA,NA,NA,NA,YES,Erica,MAYBE,Ayomide,Ayomide,Ayomide,yes
15289,YES,Nucleo2013,Article,"We report the emergence of VIM-1 MBL and CTX-M-15-producing K. pneumoniae isolates collected from patients at two acute care hospitals (I.R.C.C.S. {""}S. Matteo{""} and {""}Casa Sollievo della Sofferenza{""} Hospital) and a long-term rehabilitation facility in Northern Italy (I.R.C.C.S. {""}S. Maugeri{""}). Between February 2007 and October 2008, 30 K. pneumoniae strains showing decreased susceptibility to carbapenems were collected. PCR and sequencing experiments revealed the presence of blaVIM-1 gene in 14/30 isolates. All the above isolates carried the blaSHV-5 determinant as well; interestingly, 8/14 VIM positive isolates were also CTX-M-1- like producers. VIM-1 positive strains were present in all hospitals. PFGE genomic profiles of the 14/30 isolates showed that 2 different clones, A and B, were responsible for outbreaks. The coexistence in the same bacterial cell of compatible plasmids carrying epidemiologically important emerging resistance genes, such as MBLs and CTX-Ms, is worrisome since it could predict the generation and spread of pan-resistant bacteria and the consequent treatment option limitations that can lead to significant morbidity and mortality. Control measures should be applied to detect MBL-producing strains and to contrast the vertical and plasmidic diffusion of carbapenem-resistant K. pneumoniae in acute care and rehabilitation facilities.",E Nucleo and M Spalla and A Piazza and M S Caltagirone and S Asticcioli and M Debiaggi and C Matti and R Daturi and A Navarra and M Labonia and R Migliavacca,"1121-7138 (Print)1121-7138",New Microbiol,"Anti-Infective Agents/*pharmacology,Carbapenems/*pharmacology,Cross Infection,DNA, Bacterial/chemistry/genetics,Drug Resistance, Multiple, Bacterial,Electrophoresis, Gel, Pulsed-Field,Hospitals,Humans,Italy/epidemiology,Klebsiella Infections/epidemiology/*microbiology,Klebsiella pneumoniae/drug effects/enzymology/gene,Microbial Sensitivity Tests,Plasmids/genetics,Polymerase Chain Reaction,Rehabilitation Centers,beta-Lactamases/*genetics/metabolism",279--282,{Emergence of a VIM-1 MBL and CTX-M-15 ESbL-producing Klebsiella pneumoniae clone from acute and rehabilitation hospitals in Italy},NA,36,2013,3,"Nucleo, ElisabettaSpalla, MelissaPiazza, AuroraCaltagirone, Maria SofiaAsticcioli, SaraDebiaggi, MauriziaMatti, CarolinaDaturi, RossanaNavarra, AntonellaLabonia, MariaMigliavacca, RobertaJournal ArticleItalyNew Microbiol. 2013 Jul;36(3):279-82. Epub 2013 Jun 30.",NA,8/6/13,eng,23912869,YES,Brooke,YES,Nchedo,Nchedo,Ayomide,yes
14906,YES,Navon-Venezia2006,Article,"Carbapenem resistance in Escherichia coli is rare. We report four genetically unrelated carbapenem-resistant E. coli isolates cultured from four patients hospitalized in Tel Aviv Medical Center. PCR, sequencing, and Southern blot analysis identified KPC-2 as the imipenem-hydrolyzing enzyme in all four strains, carried on different plasmids with a possible common origin. This is the first discovery of KPC-2 in E. coli and the first report of this enzyme originating outside the United States.",S Navon-Venezia and I Chmelnitsky and A Leavitt and M J Schwaber and D Schwartz and Y Carmeli,"0066-4804 (Print)0066-4804",Antimicrob Agents Chemother,",Carbapenems/*pharmacology,Escherichia coli,Escherichia coli/*drug effects/enzymology/*genetic,Humans,Hydrolysis,Imipenem/*metabolism,Israel,Plasmids/genetics,Southern blotting,amikacin,antibiotic resistance,article,aztreonam,bacterial enzyme,bacterial infection,bacterial strain,bacterium culture,bacterium isolate,beta lactamase,beta-Lactam Resistance/genetics,beta-Lactamases/*genetics/metabolism,carbapenem,cefepime,ceftazidime,ceftriaxone,cefuroxime,cephalosporin derivative,ciprofloxacin,clone,cotrimoxazole,ertapenem,gene sequence,gentamicin,hospital patient,human,hydrolase,imipenem,length of stay,meropenem,metronidazole,nitrocefin,nonhuman,piperacillin plus tazobactam,plasmid,polymerase chain reaction,priority journal,protein kpc 2,quinoline derived antiinfective agent,treatment outcome,unclassified drug,urinary tract infection",3098--3101,{Plasmid-mediated imipenem-hydrolyzing enzyme KPC-2 among multiple carbapenem-resistant Escherichia coli clones in Israel},http://www.embase.com/search/results?subaction=viewrecord{\&}from=export{\&}id=L44396417 http://dx.doi.org/10.1128/AAC.00438-06 http://rd8hp6du2b.search.serialssolutions.com?sid=EMBASE{\&}issn=00664804{\&}id=doi:10.1128{\%}2FAAC.00438-06{\&}atitle=Plasmid-mediated+imipenem,50,2006,9,"From Duplicate 1 (Plasmid-mediated imipenem-hydrolyzing enzyme KPC-2 among multiple carbapenem-resistant Escherichia coli clones in Israel - Navon-Venezia, S; Chmelnitsky, I; Leavitt, A; Schwaber, M J; Schwartz, D; Carmeli, Y)Navon-Venezia, ShiriChmelnitsky, InnaLeavitt, AzitaSchwaber, Mitchell JSchwartz, DavidCarmeli, YehudaJournal ArticleResearch Support, Non-U.S. Gov'tUnited StatesAntimicrob Agents Chemother. 2006 Sep;50(9):3098-101.",10.1128/aac.00438-06,8/31/06,eng,16940107,YES,Melanie,YES,Erica,Erica,Ayomide,yes
13399,YES,Matlani2016,Article,We report an unusual morphological mucoid variant of Staphylococcus haemolyticus associated with linezolid resistance from a patient with sepsis. Linezolid resistance and mucoid character together made this pathogen difficult to treat. To our knowledge this is the first such report.,M Matlani and T Shende and V Bhandari and R Dawar and R Sardana and R Gaind,2052-2975,New Microbes and New Infections,"India,RNA 16S,Staphylococcus haemolyticus,adult,antibiotic sensitivity,article,brain contusion,case report,computer assisted tomography,consciousness disorder,echography,emergency ward,erythrocyte sedimentation rate,fever,human,intensive care unit,leukocyte count,linezolid,liver injury,male,middle aged,minimum inhibitory concentration,nonhuman,polymerase chain reaction,priority journal,sepsis,subarachnoid hemorrhage,tertiary care center,tissue injury,traffic accident,virus gene",57--58,{Linezolid-resistant mucoid Staphylococcus haemolyticus from a tertiary-care centre in Delhi},http://www.embase.com/search/results?subaction=viewrecord{\&}from=export{\&}id=L609159747 http://dx.doi.org/10.1016/j.nmni.2016.02.010 http://rd8hp6du2b.search.serialssolutions.com?sid=EMBASE{\&}issn=20522975{\&}id=doi:10.1016{\%}2Fj.nmni.2016.02.010{\&}atitle=Linezolid-re,11,2016,NA,NA,NA,NA,NA,NA,MAYBE,Jake,YES,Erica,Erica,Ayomide,yes
10558,YES,Kidambi2015,Article,NA,T D Kidambi and C Lee and R J Kohlwes,"1525-14970884-8734",Journal of General Internal Medicine,"Lemierre syndrome,Staphylococcus aureus,Staphylococcus infection,adult,antibiotic agent,article,case report,computer assisted tomography,external jugular vein,female,fever,human,intravenous drug abuse,methicillin resistant Staphylococcus aureus,neck pain,odynophagia,treatment duration,vein thrombosis",1886--1887,{MRSA-Associated Lemierre's Syndrome in an Intravenous Drug User},http://www.embase.com/search/results?subaction=viewrecord{\&}from=export{\&}id=L602794803 http://dx.doi.org/10.1007/s11606-015-3259-9 http://rd8hp6du2b.search.serialssolutions.com?sid=EMBASE{\&}issn=15251497{\&}id=doi:10.1007{\%}2Fs11606-015-3259-9{\&}atitle=MRSA-Associate,30,2015,12,NA,NA,NA,NA,NA,MAYBE,Cale,YES,Nchedo,Nchedo,Ayomide,yes
9885,YES,Jovcic2011,Article,"This work reports, for the first time, the presence of New Delhi metallo-beta-lactamase 1 (NDM-1) in Pseudomonas aeruginosa. Moreover, this is the first report of the NDM-1 presence in the Balkan region. Cosmid gene libraries of carbapenem-nonsusceptible Pseudomonas aeruginosa clinical isolates MMA83 and MMA533 were screened for the presence of metallo-beta-lactamases. Accordingly, both MMA83 and MMA533 carried the bla(NDM-1) gene. Pulsed-field gel electrophoresis (PFGE) analysis indicated that strains MMA83 and MMA533 belonged to different clonal groups. Five additional isolates from different patients clonally related to either MMA83 or MMA533 were found to be NDM-1 positive.",B Jovcic and Z Lepsanovic and V Suljagic and G Rackov and J Begovic and L Topisirovic and M Kojic,0066-4804,Antimicrob Agents Chemother,"*beta-Lactam Resistance,Anti-Bacterial Agents/*pharmacology,Carbapenems/*pharmacology,Drug Resistance, Multiple, Bacterial,Electrophoresis, Gel, Pulsed-Field,Female,Humans,Microbial Sensitivity Tests,Middle Aged,Molecular Sequence Data,Pseudomonas Infections/microbiology,Pseudomonas aeruginosa/*drug effects/*enzymology/g,Serbia,beta-Lactamases/*genetics/metabolism,purification",3929--3931,{Emergence of NDM-1 metallo-beta-lactamase in Pseudomonas aeruginosa clinical isolates from Serbia},NA,55,2011,8,"1098-6596Jovcic, BrankoLepsanovic, ZoricaSuljagic, VesnaRackov, GorjanaBegovic, JelenaTopisirovic, LjubisaKojic, MilanJournal ArticleResearch Support, Non-U.S. Gov'tUnited StatesAntimicrob Agents Chemother. 2011 Aug;55(8):3929-31. doi: 10.1128/AAC.00226-11. Epub 2011 Jun 6.",10.1128/aac.00226-11,6/8/11,eng,21646490,YES,Melanie,YES,Erica,Erica,Ayomide,yes
7482,YES,Gomez-Garces2011,Article,NA,J L GÕ_mez-GarcÕ©s and D SaÕ©z and M Almagro and S FernÕçndez-Romero and F Merino and J Campos and J Oteo,"0732-88931879-0070",Diagnostic Microbiology and Infectious Disease,"Aeromonas hydrophila,DNA sequence,Pseudomonas aeruginosa,adult,amikacin,amoxicillin plus clavulanic acid,ampicillin,antibiotic sensitivity,bacterial gene,beta lactamase CTX M,beta lactamase CTX M15,blaCTX M 15 gene,case report,cefazolin,cefepime,cefotaxime,cefoxitin,ceftazidime,ciprofloxacin,comminuted fracture,cotrimoxazole,ertapenem,external fixator,female,fever,fibula fracture,gentamicin,human,imipenem,intraarticular fracture,letter,levofloxacin,linezolid,meropenem,methicillin resistant Staphylococcus aureus,nonhuman,ofloxacin,open fracture,osteomyelitis,piperacillin,piperacillin plus tazobactam,priority journal,rifampicin,tibia fracture,tobramycin,unclassified drug,vancomycin",420--422,{Osteomyelitis associated to CTX-M-15-producing Aeromonas hydrophila: First description in the literature},http://www.embase.com/search/results?subaction=viewrecord{\&}from=export{\&}id=L51404158 http://dx.doi.org/10.1016/j.diagmicrobio.2011.03.004 http://rd8hp6du2b.search.serialssolutions.com?sid=EMBASE{\&}issn=07328893{\&}id=doi:10.1016{\%}2Fj.diagmicrobio.2011.03.004{\&}atit,70,2011,3,NA,NA,NA,NA,NA,YES,Brooke,YES,Zach,Zach,Ayomide,yes
5451,MAYBE,Douvoyiannis2010,Article,"Chryseobacterium species are a rare cause of human disease and are usually associated with indwelling devices or altered immune status. This is the first case to our knowledge, of Chryseobacterium indologenes bacteremia in a previously healthy infant. Chryseobacteria are pathogens resistant to the usual empiric treatments for neonatal or infantile septicemia.",M Douvoyiannis and S Kalyoussef and G Philip and M M Mayers,1201-9712,Int J Infect Dis,",Anti-Bacterial Agents/therapeutic use,Bacteremia/*diagnosis/drug therapy/*microbiology,Cephalosporins/therapeutic use,Chryseobacterium indologenes,Chryseobacterium/drug effects/*isolation {\&} purific,Female,Flavobacteriaceae Infections/*diagnosis/drug thera,Gram negative sepsis,Humans,Infant,Microbial Sensitivity Tests,Treatment Outcome,ampicillin,antibiotic sensitivity,antigen detection,article,bacterium culture,bacterium detection,bacterium identification,blood cell count,blood culture,case report,cefepime,cefotaxime,cerebrospinal fluid examination,female,fever,gentamicin,human,infant,infant disease,irritability,nose obstruction,rhinorrhea,treatment duration",e531--e532,{Chryseobacterium indologenes bacteremia in an infant},http://www.embase.com/search/results?subaction=viewrecord{\&}from=export{\&}id=L50628898 http://dx.doi.org/10.1016/j.ijid.2009.06.015 http://rd8hp6du2b.search.serialssolutions.com?sid=EMBASE{\&}issn=12019712{\&}id=doi:10.1016{\%}2Fj.ijid.2009.06.015{\&}atitle=Chryseobacter,14,2010,6,"From Duplicate 2 (Chryseobacterium indologenes bacteremia in an infant - Douvoyiannis, M; Kalyoussef, S; Philip, G; Mayers, M M)1878-3511Douvoyiannis, MiltiadisKalyoussef, SabahPhilip, GialanellaMayers, Marguerite MCase ReportsJournal ArticleCanadaInt J Infect Dis. 2010 Jun;14(6):e531-2. doi: 10.1016/j.ijid.2009.06.015. Epub 2009 Sep 2.",10.1016/j.ijid.2009.06.015,9/5/09,eng,19729329,MAYBE,Cale,MAYBE,Mushtaq,Mushtaq,Ayomide,yes
3597,YES,Chen2016a,Article,NA,D Chen and L Gong and T R Walsh and R Lan and T Wang and J Zhang and W Mai and N Ni and J Lu and J Xu and J Li,"1460-20910305-7453",Journal of Antimicrobial Chemotherapy,"China,Escherichia coli,Escherichia coli infection,amikacin,antibiotic resistance,article,aztreonam,bacterium isolate,case report,cefoperazone plus sulbactam,cefuroxime,ciprofloxacin,female,gentamicin,human,latamoxef,levofloxacin,male,ndm 5 producing Escherichia coli,nonhuman,nucleotide sequence,plasmid,polymyxin B,sequence alignment,tigecycline",563--565,{Infection by and dissemination of NDM-5-producing Escherichia coli in China},http://www.embase.com/search/results?subaction=viewrecord{\&}from=export{\&}id=L608909621 http://dx.doi.org/10.1093/jac/dkv352 http://rd8hp6du2b.search.serialssolutions.com?sid=EMBASE{\&}issn=14602091{\&}id=doi:10.1093{\%}2Fjac{\%}2Fdkv352{\&}atitle=Infection+by+and+dissemina,71,2016,2,NA,NA,NA,NA,NA,MAYBE,Brooke,YES,Ayomide,Ayomide,Ayomide,yes
3774,YES,Chiew2006,Article,NA,Y F Chiew and K D Parnell and M C Johnstone and K M Thompson and E C Penno and S J Williams,"0031-30251465-3931",Pathology,"Caucasian,Escherichia coli,aged,amoxicillin plus clavulanic acid,antibiotic resistance,antiinfective agent,augmentin,aztreonam,bacterium isolate,beta lactamase AmpC,bladder fistula,cancer radiotherapy,case report,cefepime,cefotaxime,cefoxitin,cefpodoxime,ceftazidime,colon carcinoma,colon fistula,extended spectrum beta lactamase,hemicolectomy,human,hypertension,letter,male,minimum inhibitory concentration,non insulin dependent diabetes mellitus,nonhuman,plasmid,rectum carcinoma,urinary tract infection",576--577,{A case of plasmid-mediated AmpC betalactamase-producing E. coli (PACE) and its implications [1]},http://www.embase.com/search/results?subaction=viewrecord{\&}from=export{\&}id=L47215685 http://dx.doi.org/10.1080/00313020601023914 http://rd8hp6du2b.search.serialssolutions.com?sid=EMBASE{\&}issn=00313025{\&}id=doi:10.1080{\%}2F00313020601023914{\&}atitle=A+case+of+plasm,38,2006,6,NA,NA,NA,NA,NA,NO,Cale,MAYBE,Erica,Zach,Ayomide,no
623,MAYBE,Alsultan2009,Article,"Diabetic patients are 10 times more likely to develop Acinetobacter baumannii infections than the rest of the population. Carbapenems are considered one of the very few antibiotics left to treat infections caused by this organism. The aim of this work was to characterise A. baumannii strains isolated from diabetic patients and to investigate whether there is a relationship between certain strains and low-level-carbapenem resistance. Methods: Clinical samples were collected from diabetic patients in hospitals throughout Saudi Arabia from December 2006 to April 2007. API 20 NE, polymorphisms in the 16S-23S-rRNA intergenic region and the presence of a blaOXA-51-like gene were all used for identification. Susceptibility to antimicrobials was determined using agar dilution and disk diffusion methods. Pulsed-field gel electrophoresis (PFGE) coupled with sequence analysis of the bla OXA-51-like genes were used for strain characterization. Polymerase chain reaction (PCR) and multiplex PCR were used to screen for the presence and location of ISAba1 elements and blaOXA-23-like, bla OXA-40-like, and blaOXA-58-like genes respectively. Results: Twenty isolates were identified as A. baumannii and were all highly resistant to 38{\%} of the antibiotics tested and the majority of isolates were also resistant to 50{\%} of the remaining antibiotics. Four strains had low-level meropenem resistance (MIC 4 - 8 mg/L). All isolates were sensitive to imipenem and colistin. Nine strains possessed four novel blaOXA-51-like genes encoding $\beta$-lactamases designated OXA-90, OXA-130, OXA-131 and OXA-132, and four strains contained blaOXA-131 with ISAba1 upstream of the gene structure. PFGE showed five separate clusters of OXA-51-like enzymes and the dissemination of strains carrying the four novel enzymes was clonal. This study showed that new strains of A. baumannii characterised by their new bla OXA-51-like gene have emerged. No genes encoding OXA-23-like, OXA-40-like, or OXA-58-like $\beta$-lactamases were found. Surveillance of A. baumannii harbouring the blaOXA-131-like gene may be an essential step in monitoring their carbapenem resistance phenotype and may assist in preventing their spread in diabetics. {\textcopyright} E.S.I.F.T. srl.",A A Alsultan and A Hamouda and B A Evans and S G B Amyes,1120-009X,Journal of Chemotherapy,"Acinetobacter baumannii,DNA polymorphism,adult,agar dilution,aged,amoxicillin plus clavulanic acid,ampicillin,antibiotic resistance,antibiotic sensitivity,article,bacterial strain,beta lactamase,beta lactamase oxa 130,beta lactamase oxa 131,beta lactamase oxa 132,beta lactamase oxa 23 like,beta lactamase oxa 40 like,beta lactamase oxa 51 like,beta lactamase oxa 58 like,beta lactamase oxa 90,carbapenem,chloramphenicol,ciprofloxacin,clinical article,colistin,diabetes mellitus,diabetic patient,disk diffusion,ertapenem,female,gene sequence,gene structure,gentamicin,human,imipenem,male,meropenem,multiplex polymerase chain reaction,nalidixic acid,nonhuman,nucleotide sequence,ofloxacin,oxacillin,piperacillin plus tazobactam,polymerase chain reaction,pulsed field gel electrophoresis,rifampicin,sequence analysis,sulbactam,tetracycline,unclassified drug",290--295,{Acinetobacter baumannii: Emergence of four strains with novel bla OXA-51-like genes in patients with diabetes mellitus},http://www.embase.com/search/results?subaction=viewrecord{\&}from=export{\&}id=L355067778 http://rd8hp6du2b.search.serialssolutions.com?sid=EMBASE{\&}issn=1120009X{\&}id=doi:{\&}atitle=Acinetobacter+baumannii{\%}3A+Emergence+of+four+strains+with+novel+bla+OXA-51-like+genes,21,2009,3,NA,NA,NA,NA,NA,YES,Allison,MAYBE,Zach,Zach,Ayomide,yes
172,YES,Afsar2012a,Article,"Linezolid which is the first member of oxazolidinone class of synthetic antimicrobial agents, was licensed for the treatment of gram-positive coccal infections in Turkey in 2006. In recent years, multidrug-resistant pathogens, especially vancomycin-resistant enterococci (VRE), have emerged rapidly worldwide and linezolid exhibited good clinical efficacy against VRE. However, linezolid-resistant bacteria have been reported from Turkey. In April 2011, a 66-year-old paraplegic woman was admitted to our hospital because of an infected decubitis ulcer and empirical antibiotic therapy was started. Since the patient's condition worsened during treatment, she was moved to the intensive care unit. Klebsiella pneumoniae, methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecium were recovered from tracheal aspirates and blood, respectively. Following three weeks of linezolid therapy blood culture yielded linezolid and vancomycin resistant E.faecium. Linezolid resistance in the VRE strain was confirmed by polymerase chain reaction and sequence analysis, subsequently. Linezolid-resistant two isolates were identified as E.faecium by 16S rRNA sequencing and both isolates had G2576U mutation in 23S rRNA gene. Linezolid resistance which was identified in a vancomycin-resistant E.faecium isolate is a new problem for Turkey. Last year another mutation related to linezolid resistance was reported from Istanbul, Turkey. The isolate had G2576T mutated 23S rRNA genes. Resistance should be considered and closely followed-up during linezolid treatment.",I Afsar and I Baris and A G Sener and V Koksal and M Demirci,"0374-9096 (Print)0374-9096",Mikrobiyol Bul,"Acetamides/*pharmacology,Aged,Anti-Infective Agents/*pharmacology,Drug Resistance, Multiple, Bacterial/*genetics,Enterococcus faecium/*drug effects/genetics,Female,Gram-Positive Bacterial Infections/drug therapy/*m,Humans,Linezolid,Mutation,Oxazolidinones/*pharmacology,Pressure Ulcer/complications/drug therapy,Turkey,Vancomycin Resistance",516--518,{[Linezolid-resistant Enterococcus faecium: the first G2576T mutation in Turkey]},NA,46,2012,3,"Afsar, IlhanBaris, IbrahimSener, Asli GamzeKoksal, VedatDemirci, MustafaCase ReportsEnglish AbstractLetterTurkeyMikrobiyol Bul. 2012 Jul;46(3):516-8.",NA,9/7/12,tur,22951666,YES,Brooke,YES,Erica,Erica,Ayomide,yes